352 related articles for article (PubMed ID: 16785284)
1. Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK.
García Rodríguez LA; Lagergren J; Lindblad M
Gut; 2006 Nov; 55(11):1538-44. PubMed ID: 16785284
[TBL] [Abstract][Full Text] [Related]
2. Antacid drug use and risk of esophageal and gastric adenocarcinomas in Los Angeles County.
Duan L; Wu AH; Sullivan-Halley J; Bernstein L
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):526-33. PubMed ID: 19190141
[TBL] [Abstract][Full Text] [Related]
3. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.
Vaughan TL; Farrow DC; Hansten PD; Chow WH; Gammon MD; Risch HA; Stanford JL; Schoenberg JB; Mayne ST; Rotterdam H; Dubrow R; Ahsan H; West AB; Blot WJ; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):749-56. PubMed ID: 9752982
[TBL] [Abstract][Full Text] [Related]
4. Cholecystectomy, peptic ulcer disease and the risk of adenocarcinoma of the oesophagus and gastric cardia.
Freedman J; Lagergren J; Bergström R; Näslund E; Nyrén O
Br J Surg; 2000 Aug; 87(8):1087-93. PubMed ID: 10931056
[TBL] [Abstract][Full Text] [Related]
5. H2-receptor antagonists may increase the risk of cardio-oesophageal adenocarcinoma: a case-control study.
Suleiman UL; Harrison M; Britton A; McPherson K; Bates T
Eur J Cancer Prev; 2000 Jun; 9(3):185-91. PubMed ID: 10954258
[TBL] [Abstract][Full Text] [Related]
6. Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma.
Wu AH; Tseng CC; Bernstein L
Cancer; 2003 Sep; 98(5):940-8. PubMed ID: 12942560
[TBL] [Abstract][Full Text] [Related]
7. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer.
Farrow DC; Vaughan TL; Sweeney C; Gammon MD; Chow WH; Risch HA; Stanford JL; Hansten PD; Mayne ST; Schoenberg JB; Rotterdam H; Ahsan H; West AB; Dubrow R; Fraumeni JF; Blot WJ
Cancer Causes Control; 2000 Mar; 11(3):231-8. PubMed ID: 10782657
[TBL] [Abstract][Full Text] [Related]
8. Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study.
Lindblad M; Rodríguez LA; Lagergren J
Cancer Causes Control; 2005 Apr; 16(3):285-94. PubMed ID: 15947880
[TBL] [Abstract][Full Text] [Related]
9. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
Brusselaers N; Wahlin K; Engstrand L; Lagergren J
BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
[TBL] [Abstract][Full Text] [Related]
10. Risk of Barrett's oesophagus, oesophageal adenocarcinoma and reflux oesophagitis and the use of nitrates and asthma medications.
Ladanchuk TC; Johnston BT; Murray LJ; Anderson LA;
Scand J Gastroenterol; 2010 Dec; 45(12):1397-403. PubMed ID: 20626305
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen exposure and risk of oesophageal and gastric adenocarcinoma: a population-based cohort study of breast cancer patients in Sweden.
Chandanos E; Lindblad M; Jia C; Rubio CA; Ye W; Lagergren J
Br J Cancer; 2006 Jul; 95(1):118-22. PubMed ID: 16755290
[TBL] [Abstract][Full Text] [Related]
12. Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans.
Tan MC; El-Serag HB; Yu X; Thrift AP
Aliment Pharmacol Ther; 2018 Aug; 48(4):469-477. PubMed ID: 29956826
[TBL] [Abstract][Full Text] [Related]
13. Airborne occupational exposures and risk of oesophageal and cardia adenocarcinoma.
Jansson C; Plato N; Johansson AL; Nyrén O; Lagergren J
Occup Environ Med; 2006 Feb; 63(2):107-12. PubMed ID: 16421388
[TBL] [Abstract][Full Text] [Related]
14. The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia.
Chow WH; Finkle WD; McLaughlin JK; Frankl H; Ziel HK; Fraumeni JF
JAMA; 1995 Aug; 274(6):474-7. PubMed ID: 7629956
[TBL] [Abstract][Full Text] [Related]
15. Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC).
González CA; Jakszyn P; Pera G; Agudo A; Bingham S; Palli D; Ferrari P; Boeing H; del Giudice G; Plebani M; Carneiro F; Nesi G; Berrino F; Sacerdote C; Tumino R; Panico S; Berglund G; Simán H; Nyrén O; Hallmans G; Martinez C; Dorronsoro M; Barricarte A; Navarro C; Quirós JR; Allen N; Key TJ; Day NE; Linseisen J; Nagel G; Bergmann MM; Overvad K; Jensen MK; Tjonneland A; Olsen A; Bueno-de-Mesquita HB; Ocke M; Peeters PH; Numans ME; Clavel-Chapelon F; Boutron-Ruault MC; Trichopoulou A; Psaltopoulou T; Roukos D; Lund E; Hemon B; Kaaks R; Norat T; Riboli E
J Natl Cancer Inst; 2006 Mar; 98(5):345-54. PubMed ID: 16507831
[TBL] [Abstract][Full Text] [Related]
16. Risk of cancer and acid suppressant treatment.
Langman M; Logan R
Gut; 2007 Jul; 56(7):1023. PubMed ID: 17566037
[No Abstract] [Full Text] [Related]
17. Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers.
Fortuny J; Johnson CC; Bohlke K; Chow WH; Hart G; Kucera G; Mujumdar U; Ownby D; Wells K; Yood MU; Engel LS
Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1154-1159.e3. PubMed ID: 17644046
[TBL] [Abstract][Full Text] [Related]
18. Relationship between diabetes mellitus and adenocarcinoma of the oesophagus and gastric cardia.
Rubenstein JH; Davis J; Marrero JA; Inadomi JM
Aliment Pharmacol Ther; 2005 Aug; 22(3):267-71. PubMed ID: 16091065
[TBL] [Abstract][Full Text] [Related]
19. Socioeconomic position and the risk of gastric and oesophageal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).
Nagel G; Linseisen J; Boshuizen HC; Pera G; Del Giudice G; Westert GP; Bueno-de-Mesquita HB; Allen NE; Key TJ; Numans ME; Peeters PH; Sieri S; Siman H; Berglund G; Hallmans G; Stenling R; Martinez C; Arriola L; Barricarte A; Chirlaque MD; Quiros JR; Vineis P; Masala G; Palli D; Panico S; Tumino R; Bingham S; Boeing H; Bergmann MM; Overvad K; Boutron-Ruault MC; Clavel-Chapelon F; Olsen A; Tjonneland A; Trichopoulou A; Bamia C; Soukara S; Sabourin JC; Carneiro F; Slimani N; Jenab M; Norat T; Riboli E; González CA
Int J Epidemiol; 2007 Feb; 36(1):66-76. PubMed ID: 17227779
[TBL] [Abstract][Full Text] [Related]
20. Acid inhibitory medication and risk of gastric and oesophageal cancer.
McColl KE
Gut; 2006 Nov; 55(11):1532-3. PubMed ID: 17047103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
